510(k) Report

PMA · Approved

Recalled · Class II · 2025

ColoSense®

P230001PMAApproved May 3, 2024469-day reviewClass IIIRecalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Geneoscopy, Inc. · SBB System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection

Approved on May 3, 2024 through premarket approval, which rests on the device’s own clinical evidence after a 469-day review. It has been recalled once.

Decided
May 3, 2024
Review
469 days
Class
Class III
Product code
SBB
Recalls
1

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P230001 has 12 supplements since 2024: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2024: 52025: 52026: 2
2024high 5 (2024) · low 2 (2026)2026
View FIG. 1 as a table
YearSupplements approved
20245
20255
20262
FIG. 1 — Supplements to P230001, 2024–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in SBB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 20, 2025Class IIZ-2077-2025Unknown/Undetermined by firmMultiple plate failures documented as a result of the Low Positive Template Control being too high and out of range using the affected lot of ColoSense Test Kit.

No ancestor or descendant has a Class I recall.

How does its category compare?

All SBB devices

SBB System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · SBB

5in 2025

2024: 62025: 52026 (partial year): 2
2007high 6 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · SBB

Too few SBB 510(k)s in any year since 2007 to give a median.

Recalls per year · SBB

No recall names SBB since 2007.

Adverse event reports per year · SBB

No MAUDE report names SBB since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20246—00
20255—00
20262—0—
Cite this page

510(k) Report. “P230001: ColoSense®.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/P230001

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026